Inventor
MATTHEW FORREST SAMMONS
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes25%
C07DHeterocyclic compounds22%
C07BGeneral methods of organic chemistry19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07KPeptides3%
PatentTitleYear
12,577,240Antiviral heteroaryl ketone derivatives202612,485,157Method of treating COVID-19202512,358,897Compounds and method of treating COVID-19202512,187,727Methods for antagonizing a melanocortin 4 receptor202511,926,642Compounds and methods for the treatment of COVID-19202411,643,412Melanocortin 4 receptor antagonists and uses thereof202311,541,034Nitrile-containing antiviral compounds202311,452,711Nitrile-containing antiviral compounds202211,351,149Nitrile-containing antiviral compounds2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to PFIZER (9)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 9 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2026 |